| Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial R Ruslami, AR Ganiem, S Dian, L Apriani, TH Achmad, AJ van der Ven, ... The Lancet infectious diseases 13 (1), 27-35, 2013 | 430 | 2013 |
| GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last NC Bahr, S Marais, M Caws, R Van Crevel, RJ Wilkinson, JS Tyagi, ... Clinical Infectious Diseases 62 (9), 1133-1135, 2016 | 137 | 2016 |
| Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia A van Laarhoven, S Dian, C Ruesen, E Hayati, MSMA Damen, J Annisa, ... The Journal of infectious diseases 215 (7), 1029-1039, 2017 | 106 | 2017 |
| Improving the microbiological diagnosis of tuberculous meningitis: a prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain … AD Heemskerk, J Donovan, S Marais, L Chaidir, VTM Dung, CM Centner, ... Journal of Infection 77 (6), 509-515, 2018 | 104 | 2018 |
| Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis L Te Brake, S Dian, AR Ganiem, C Ruesen, D Burger, R Donders, ... International journal of antimicrobial agents 45 (5), 496-503, 2015 | 96 | 2015 |
| Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study A van Laarhoven, S Dian, R Aguirre-Gamboa, J Avila-Pacheco, ... The Lancet Infectious Diseases 18 (5), 526-535, 2018 | 91 | 2018 |
| Double-blind, randomized, placebo-controlled phase II dose-finding study to evaluate high-dose rifampin for tuberculous meningitis S Dian, V Yunivita, AR Ganiem, T Pramaesya, L Chaidir, K Wahyudi, ... Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01014-18, 2018 | 89 | 2018 |
| Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients V Yunivita, S Dian, AR Ganiem, E Hayati, TH Achmad, AP Dewi, M Teulen, ... International journal of antimicrobial agents 48 (4), 415-421, 2016 | 76 | 2016 |
| Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculous meningitis trials EM Svensson, S Dian, L Te Brake, AR Ganiem, V Yunivita, ... Clinical Infectious Diseases 71 (8), 1817-1823, 2020 | 75 | 2020 |
| Cerebral toxoplasmosis in HIV-infected patients: a review S Dian, AR Ganiem, S Ekawardhani Pathogens and global health 117 (1), 14-23, 2023 | 64 | 2023 |
| Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis RC Sofiati Dian, Robby Hermawan, Arjan van Laarhoven, Sofia Immaculata, Tri ... Plos One, 2020 | 59 | 2020 |
| Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward J Donovan, FV Cresswell, NTT Thuong, DR Boulware, GE Thwaites, ... Clinical Infectious Diseases 71 (8), 2002-2005, 2020 | 47 | 2020 |
| Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia L Chaidir, J Annisa, S Dian, I Parwati, A Alisjahbana, F Purnama, ... Diagnostic microbiology and infectious disease 91 (1), 42-46, 2018 | 45 | 2018 |
| Central nervous system tuberculosis S Dian, AR Ganiem, A van Laarhoven Current opinion in neurology 34 (3), 396-402, 2021 | 44 | 2021 |
| Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia AR Ganiem, S Dian, A Indriati, L Chaidir, R Wisaksana, P Sturm, ... PLoS neglected tropical diseases 7 (1), e1994, 2013 | 41 | 2013 |
| Management of intracranial tuberculous mass lesions: how long should we treat for? S Marais, R Van Toorn, FC Chow, A Manesh, OK Siddiqi, A Figaji, ... Wellcome open research 4, 158, 2020 | 38 | 2020 |
| Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study A van Laarhoven, S Dian, S van Dorp, F Purnama, VACM Koeken, ... Scientific reports 9 (1), 884, 2019 | 37 | 2019 |
| Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study D Imran, R Estiasari, K Maharani, Sucipto, DC Lestari, RE Yunus, ... Neurology: Clinical Practice 8 (5), 379-388, 2018 | 36 | 2018 |
| Large-scale genomic analysis shows association between homoplastic genetic variation in Mycobacterium tuberculosis genes and meningeal or pulmonary … C Ruesen, L Chaidir, A van Laarhoven, S Dian, AR Ganiem, ... BMC genomics 19, 1-11, 2018 | 23 | 2018 |
| Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis E Ardiansyah, J Avila-Pacheco, S Dian, DN Vinh, HT Hai, K Bullock, ... Elife 12, e85307, 2023 | 16 | 2023 |
